levonorgestrel has been researched along with c-peptide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V | 1 |
Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
Laatikainen, T; Raudaskoski, T; Tomás, C | 1 |
Düsterberg, B; Endrikat, J; Gerlinger, C; Goldstein, H; Jespersen, J; Schmidt, W; Skouby, SO; Wessel, J | 1 |
1 trial(s) available for levonorgestrel and c-peptide
Article | Year |
---|---|
A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Denmark; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids, Nonesterified; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Prospective Studies; Time Factors; Treatment Outcome; Triglycerides | 2005 |
4 other study(ies) available for levonorgestrel and c-peptide
Article | Year |
---|---|
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes | 1992 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
Topics: Administration, Cutaneous; Blood Glucose; C-Peptide; Estradiol; Female; Hormone Replacement Therapy; Humans; Hysterectomy; Insulin; Insulin Resistance; Levonorgestrel; Middle Aged; Postmenopause; Progesterone Congeners | 1999 |